Recurrent Lymphoma, Mantle-Cell
1 clinical trials · Condition
◉ Watch Recurrent Lymphoma, Mantle-Cell
| Record | Firm | Date |
|---|---|---|
| Optimal Dose Finding Study ABT-199 and Ibrutinib in MCL (NCT02419560) | Craig Portell, MD | 2015-04-01 |
Track Recurrent Lymphoma, Mantle-Cell automatically
Every clearance here is in the API, with alerts when new ones post.